voltarol 140 mg
glaxosmithkline consumer healthcare a/s (1) - diklofenaknatrium - medisinert plaster - 140 mg
zantac 150 mg
glaxosmithkline as - ranitidinhydroklorid - brusetablett - 150 mg
zantac 25 mg/ ml
glaxosmithkline as - ranitidinhydroklorid - injeksjonsvæske, oppløsning - 25 mg/ ml
zantac 150 mg
glaxosmithkline as - ranitidinhydroklorid - tablett - 150 mg
zovirax 800 mg
glaxosmithkline as - aciklovir - tablett - 800 mg
zovirax 80 mg/ ml
glaxosmithkline as - aciklovir - mikstur, suspensjon - 80 mg/ ml
zovirax 200 mg
glaxosmithkline as - aciklovir - tablett - 200 mg
zovirax 30 mg/ g
glaxosmithkline as - aciklovir - Øyesalve - 30 mg/ g
zyban 150 mg
glaxosmithkline as - bupropionhydroklorid - depottablett - 150 mg
arexvy
glaxosmithkline biologicals s.a. - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - respiratorisk syncytialvirusinfeksjoner - vaksiner - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger.